Semaglutide Injections Guide: How It Works, Safety and Dosing

By the ShopMedRx team. Last updated October 11, 2026. This article is educational and is not medical advice.

This semaglutide injections guide covers the basics: semaglutide is a prescription medicine given as a once-weekly injection under the skin, and it is studied for chronic weight management in adults alongside diet and physical activity. Whether it is appropriate for you is a decision for a licensed clinician after reviewing your health history. Below you will find how it works, who a clinician may consider it for, how dosing is usually structured, the main risks, and what to ask before you start.

Semaglutide injections guide at a glance

• What it is: a prescription GLP-1 receptor agonist, a long-acting GLP-1 analogue given by injection once a week.^[11]
• Who decides: a licensed clinician. It is prescription-only and is prescribed only if appropriate after a clinician reviews your health information.
• Compounded status: semaglutide injections through ShopMedRx are compounded medications. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality.^[1]
• Dosing: treatment usually starts low and increases step by step. Your clinician sets your dose.
• Main risks: stomach and digestive side effects are common. Serious risks include a boxed warning about thyroid C-cell tumors, pancreatitis, gallbladder disease and dehydration that can harm the kidneys.^[4][2]
• Not a stand-alone fix: it is meant to be used with a reduced-calorie diet and more physical activity.^[4]

What semaglutide injections are

Semaglutide is a medicine in the GLP-1 receptor agonist class. In the research literature it is described as a long-acting, subcutaneous GLP-1 analogue, which is why one injection a week is enough.^[11] "Subcutaneous" means the medicine goes into the fatty tissue just under the skin, not into a vein or muscle.

The FDA label for semaglutide 2.4 mg injection lists its use together with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity, or in adults with overweight and at least one weight-related condition.^[2] Dose levels and uses differ across semaglutide products, so rely on your clinician's instructions for your own prescription.

This guide is about semaglutide injections prescribed by an independent clinician and filled by a licensed U.S. pharmacy. It does not replace the instructions you receive from your clinician or pharmacist.

How semaglutide injections work

Semaglutide works on the GLP-1 pathway, a hormone system involved in blood sugar regulation. The FDA label notes that semaglutide lowers blood glucose, which is why low blood sugar can be a concern for some people.^[2] Clinicians also discuss how this pathway relates to appetite and digestion, which is why stomach-related side effects are the most common ones people notice.

Because the medicine is long-acting, it stays in the body for a while after each dose. The FDA label says semaglutide can be present in the bloodstream for about 5 to 7 weeks after the last 2.4 mg injection.^[2] That long window matters for side effects, for missed doses and for pregnancy planning, all covered below.

What the main clinical trial found

The best-known trial is STEP 1, which studied FDA-approved semaglutide 2.4 mg injection. It enrolled 1,961 adults with obesity, or with overweight plus a weight-related condition, and without diabetes. Participants received semaglutide or placebo for 68 weeks, alongside lifestyle support. The average change in body weight was a 14.9% decrease with semaglutide and a 2.4% decrease with placebo.^[5] Individual results vary, and the trial was funded by the drug's manufacturer.

Those results came from a specific FDA-approved product, studied under trial conditions with regular lifestyle counseling. Compounded medications have not been reviewed by the FDA, so trial findings should not be read as a promise of what any compounded product will do for you.

Who may be suitable for semaglutide injections

If you are wondering who qualifies for semaglutide, the honest answer is that it depends on your health history, and only a licensed clinician can decide. For reference, the STEP trials enrolled adults with a body mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition.^[5] The FDA label for the approved 2.4 mg product refers to adults with obesity, or with overweight and at least one weight-related condition.^[2] Clinicians often use those groups as a starting point, then look at the whole picture.

A clinician may also consider:

• Your current medicines, especially insulin or other diabetes medicines
• Your personal and family medical history
• Past weight-management efforts and what you want from treatment
• Whether you are pregnant, breastfeeding or planning a pregnancy
• Whether other treatments might be a better fit

Treatment is for adults 18 and older. Being eligible on paper does not guarantee a prescription. A clinician may decide semaglutide is not right for you.

Who should not take semaglutide, or needs extra caution

The FDA label lists these key points. Read them with your clinician, and do not treat this list as complete.

• Thyroid cancer history: semaglutide should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or with multiple endocrine neoplasia syndrome type 2 (MEN 2).^[4]
• Allergy: it should not be used if you have a known serious allergy to semaglutide or any ingredient in the product.^[4]
• Severe gastroparesis: the label says semaglutide 2.4 mg is not recommended in people with severe gastroparesis (very slow stomach emptying).^[8]
• Insulin or sulfonylureas: using these with semaglutide can raise the risk of low blood sugar.^[2]
• Diabetic eye disease: the label describes diabetic retinopathy complications in people with type 2 diabetes, so tell your clinician about any eye conditions.^[2]
• Pregnancy: the FDA label says to stop semaglutide 2.4 mg at least 2 months before a planned pregnancy because of how long it stays in the body.^[2]

How treatment starts with ShopMedRx

ShopMedRx is a cash-pay telehealth company. We do not prescribe. Here is how the process works:

1. You complete an online health assessment.
2. An independent, licensed clinician, working through OpenLoop Health, reviews your information and decides whether a prescription is appropriate. They may ask follow-up questions or decide not to prescribe.
3. If a prescription is written, a licensed U.S. partner pharmacy prepares and ships it.
4. You follow your clinician's instructions and stay in touch about side effects, dose changes and progress.

You can read about the program on our semaglutide injections page. There is no guarantee of approval and no instant access: a clinician has to review you first.

Compounded semaglutide: what that means

Most medicines at ShopMedRx, including semaglutide injections, are compounded. A compounded drug is made by a pharmacy for an individual patient on a prescription. The FDA is clear on this point: compounded drugs are not FDA-approved, and the agency does not review them for safety, effectiveness or quality before they are marketed.^[1] The FDA also notes that a compounded drug might be appropriate when a patient's medical need cannot be met by an FDA-approved drug or when the approved drug is not commercially available.^[1]

The FDA has raised specific concerns about compounded semaglutide and tirzepatide, including dosing errors, unapproved salt forms and adverse events, some requiring hospitalization.^[9] It has also received reports of injectable products arriving warm or improperly cooled, and it advises against using a shipment that arrived that way.^[10] In 2026 the agency said it intends to restrict the active ingredients used in some mass-marketed compounded GLP-1 drugs, so the rules in this area are changing.^[10] Ask your clinician what is currently available and appropriate for you.

Red flags to watch for when using any online service

The FDA lists warning signs for telehealth companies selling these medicines.^[1] Use them as a checklist:

• A company says a compounded drug is identical to an FDA-approved drug
• Prices that seem too good to be true
• Medicine that looks different from what the website showed, or arrives damaged or without instructions
• No screening or prescription by a licensed doctor before medicine is sent

Semaglutide dosing in general terms

Semaglutide dosing is built around slow increases. The goal is to give the body time to adjust and to reduce stomach side effects. For FDA-approved semaglutide 2.4 mg injection, the label schedule is below.^[3]

Treatment weeks	Phase	Weekly dose in the FDA label schedule
1 to 4	Initiation	0.25 mg
5 to 8	Escalation	0.5 mg
9 to 12	Escalation	1 mg
13 to 16	Escalation	1.7 mg
17 onward	Maintenance	1.7 mg or 2.4 mg

The label also says that if a dose is not tolerated during escalation, a clinician can consider delaying the next increase by 4 weeks.^[4] The table is a simplified view of one product's labeling, not a dosing plan.

Compounded semaglutide has no FDA-reviewed label of its own. Your clinician sets the dose and schedule, and the FDA has advised clinicians to use caution when choosing doses, titration and schedules for compounded semaglutide.^[7] Because dosing errors are one of the FDA's stated concerns, ask your clinician and pharmacist to explain in writing:

• Your dose in milligrams and how much liquid to draw up or dial
• The type of syringe or device to use
• How to store the medicine and how long it stays good after first use
• When and how your dose may change

Some clinicians also prescribe smaller doses outside the labeled schedule, or an oral form. These are off-label or different-form approaches, and they are decisions for a clinician, not something to start on your own. If you are curious, see our semaglutide microdose injection page or our oral semaglutide program and ask a clinician whether either fits your situation. We make no claim that one approach works better than another.

How a weekly injection is used

The label for semaglutide 2.4 mg injection says it is given once weekly under the skin of the abdomen, thigh or upper arm.^[4] Many people choose one day of the week and keep to it so the routine is easy to remember. Your pharmacy and clinician will explain the exact technique for your product, including how to rotate sites and how to dispose of used needles.

Injectable GLP-1 medicines need to be kept cold. If your package arrives warm, damaged or without directions, contact the pharmacy and your clinician before using it.^[10] If you miss a dose, do not guess. Follow the instructions you were given or call your clinician.

Semaglutide side effects and safety

Common side effects

The most common side effects are digestive. In the pooled trial data in the FDA label for semaglutide 2.4 mg injection, nausea was reported by 44% of people taking semaglutide versus 16% taking placebo, and diarrhea by 30% versus 16%.^[6] Vomiting, constipation, abdominal pain, headache and fatigue are also on the label's list of common reactions.^[3] In those trials, 6.8% of people on 2.4 mg stopped treatment because of side effects, compared with 3.2% on placebo.^[8]

Many side effects are tied to dose increases, which is one reason clinicians raise doses gradually. Tell your clinician if side effects are strong or do not improve. Do not change your dose on your own.

Serious risks

• Thyroid C-cell tumors (boxed warning): in rodents, semaglutide caused thyroid C-cell tumors at clinically relevant exposures. It is unknown whether it does so in humans.^[4]
• Pancreatitis: symptoms include severe abdominal pain that may spread to the back, with or without nausea or vomiting. The label says to stop the medicine and contact a clinician if pancreatitis is suspected.^[2]
• Gallbladder disease: it occurred in clinical trials, and a clinician should follow up if gallstones are suspected.^[2]
• Low blood sugar: the risk is higher when semaglutide is used with insulin or sulfonylureas.^[2] In one trial of adults with type 2 diabetes, low blood sugar was reported in 6.2% on semaglutide versus 2.5% on placebo.^[2]
• Dehydration and kidney injury: the label advises monitoring kidney function in people with reactions that could lead to volume depletion, such as ongoing vomiting or diarrhea.^[8]
• Allergic reactions: hypersensitivity reactions are listed among the serious adverse reactions.^[3]

Seek urgent medical care for severe belly pain, repeated vomiting, signs of a serious allergic reaction or any symptom that worries you. This list is not complete, so read the information that comes with your medicine. If you could become pregnant, talk with your clinician about timing before you start.

What happens if you stop semaglutide

This is one of the most common questions, and the research answer is plain. In the STEP 1 extension, participants who stopped semaglutide and the structured lifestyle program regained about two-thirds of the weight they had lost within a year.^[12] On average they regained 11.6 percentage points, and weight stayed 5.6% below the starting point at week 120.^[12] Health markers such as blood pressure and waist size also moved back toward where they started for most measures.^[12] Individual results vary.

The takeaway is not that you must stay on medicine forever. It is that you should talk about the long-term plan with your clinician before you begin, and again before you stop. Ask what your plan would look like if you needed to pause, for example because of side effects or pregnancy planning.

Diet, activity and daily habits

Semaglutide is labeled as an add-on to a reduced-calorie diet and more physical activity, not a replacement for them.^[4] Our post on what to eat on a GLP-1 medicine covers meals and side effect tips, so we do not repeat it here. If you are wondering about strength training or supplements for muscle, see creatine and muscle on a GLP-1. A simple note of your injection day, dose and symptoms is also useful to share at follow-ups.

What to ask a licensed clinician

Come to your review with questions. They help you understand the plan and spot problems early. Do not put your personal health details in public places such as comments or social media.

1. Is semaglutide appropriate for me, and what else should we consider?
2. How will you decide my starting dose, and when might it change?
3. What side effects should I expect, and which ones mean I should call you or seek urgent care?
4. Do any of my current medicines or conditions change the risks, including diabetes medicines?
5. What should I do about a missed dose or a shipment that arrives warm?
6. What is the plan if I want to stop, or if I am planning a pregnancy?

Frequently asked questions

How often are semaglutide injections taken?

The label for semaglutide 2.4 mg injection describes a once-weekly injection under the skin of the abdomen, thigh or upper arm.^[4] Your clinician will tell you which day and dose to use. Follow the instructions that come with your prescription.

Do I need a prescription for semaglutide injections?

Yes. Semaglutide is prescription-only. A licensed clinician reviews your health information and decides whether it is appropriate, and they may decline to prescribe it.

Is compounded semaglutide FDA-approved?

No. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they are marketed.^[1] A clinician can explain why they think a compounded medicine is appropriate for you and what the risks are.

What are the most common semaglutide side effects?

Digestive effects such as nausea, diarrhea, vomiting, constipation and abdominal pain are the most common.^[3] Serious risks include pancreatitis, gallbladder disease, low blood sugar with certain medicines, and kidney injury from dehydration.^[2][8] Call your clinician if side effects are severe or do not go away.

Can I stop semaglutide whenever I want?

You can talk with your clinician about stopping at any time, and you should do so before changing your treatment. In a trial extension, people who stopped semaglutide regained about two-thirds of their lost weight within a year, though individual results vary.^[12] Planning ahead helps you and your clinician choose next steps.

Is semaglutide safe during pregnancy?

The FDA label says semaglutide may cause fetal harm and advises stopping at least 2 months before a planned pregnancy.^[2] If you are pregnant, trying to become pregnant or breastfeeding, talk with a clinician first.

Talk to a licensed clinician

If you want to know whether semaglutide injections may be appropriate for you, the next step is a clinician's review. Complete a short online health assessment, and an independent licensed clinician will decide whether a prescription is right. A prescription is not guaranteed.

Check if you qualify

This article is for adults 18 and older and is for education only. It is not medical advice. Talk to a licensed clinician before starting, stopping or changing any treatment.

Important information

• This article is for general education and is not medical advice. Talk to a licensed clinician before starting, stopping or changing any treatment.
• All medications available through ShopMedRx are prescription only and are prescribed only if appropriate after a licensed clinician's review.
• Some medications we offer are compounded. Compounded medications are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. They are not the same as, or generic versions of, brand-name drugs.
• Individual results vary. Nothing in this article promises a specific result.
• Prescriptions are written by independent, licensed clinicians through OpenLoop Health and filled by licensed U.S. partner pharmacies.

Sources

1. U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. FDA, 2026 (page updated). https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
2. Novo Nordisk. Semaglutide injection 2.4 mg and tablets: prescribing information (indications, pregnancy, warnings and precautions, adverse reactions). U.S. FDA, 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s033lbl.pdf
3. Novo Nordisk. Semaglutide injection 2.4 mg: label information (dosage, most common adverse reactions). DailyMed, National Library of Medicine, accessed 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5e548d0-cc79-4c34-a3f5-e20a5b8b6564
4. Novo Nordisk. Semaglutide injection and tablets for weight management: label information (boxed warning, contraindications, administration, dosage modification). DailyMed, National Library of Medicine, accessed 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
5. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, March 18, 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
6. Novo Nordisk. Semaglutide injection 2.4 mg: prescribing information (initial approval label, adverse reactions table). U.S. FDA, 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
7. National Association of Boards of Pharmacy. FDA Issues Alert: Concerns Related to Taking Unapproved GLP-1 Receptor Agonist Drugs. NABP, 2025. https://nabp.pharmacy/news/blog/regulatory_news/fda-issues-alert-concerns-related-to-taking-unapproved-glp-1-receptor-agonist-drugs/
8. Novo Nordisk. Semaglutide injection 2.4 mg: prescribing information (discontinuation rates, kidney injury, gastroparesis). U.S. FDA, 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s024lbl.pdf
9. U.S. Food and Drug Administration. FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients. U.S. FDA press announcement, 2025. https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingredients
10. American Journal of Managed Care. FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads. AJMC, 2026. https://www.ajmc.com/view/fda-to-restrict-ingredients-used-in-mass-marketed-compounded-glp-1s-crack-down-on-misleading-ads
11. Once-weekly subcutaneous semaglutide 2.4 mg reduces body weight in adults with overweight or obesity regardless of baseline characteristics (STEP 1 post-hoc analysis). PubMed Central, National Library of Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC8089676
12. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9542252/